鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/06/10 | 3,285 | 3,395 | 3,205 | 3,265 | +45 | +1.4% | 85,000 |
2020/06/09 | 3,150 | 3,230 | 3,115 | 3,220 | +130 | +4.2% | 54,300 |
2020/06/08 | 3,155 | 3,155 | 3,075 | 3,090 | -60 | -1.9% | 32,100 |
2020/06/05 | 3,180 | 3,180 | 3,105 | 3,150 | +5 | +0.2% | 25,600 |
2020/06/04 | 3,195 | 3,195 | 3,105 | 3,145 | -20 | -0.6% | 29,600 |
2020/06/03 | 3,230 | 3,230 | 3,125 | 3,165 | -40 | -1.2% | 40,100 |
2020/06/02 | 3,250 | 3,250 | 3,190 | 3,205 | -15 | -0.5% | 25,500 |
2020/06/01 | 3,295 | 3,295 | 3,185 | 3,220 | -25 | -0.8% | 35,000 |
2020/05/29 | 3,195 | 3,315 | 3,195 | 3,245 | +55 | +1.7% | 75,500 |
2020/05/28 | 3,135 | 3,220 | 3,085 | 3,190 | +110 | +3.6% | 77,200 |
2020/05/27 | 3,000 | 3,110 | 2,966 | 3,080 | +81 | +2.7% | 89,000 |
2020/05/26 | 2,996 | 3,010 | 2,926 | 2,999 | ±0 | ±0% | 63,700 |
2020/05/25 | 2,995 | 3,010 | 2,926 | 2,999 | +28 | +0.9% | 50,100 |
2020/05/22 | 2,998 | 2,998 | 2,928 | 2,971 | -20 | -0.7% | 61,200 |
2020/05/21 | 2,981 | 3,000 | 2,947 | 2,991 | -9 | -0.3% | 93,000 |
2020/05/20 | 2,860 | 3,020 | 2,839 | 3,000 | +156 | +5.5% | 90,500 |
2020/05/19 | 2,899 | 2,906 | 2,817 | 2,844 | -18 | -0.6% | 51,700 |
2020/05/18 | 2,849 | 2,881 | 2,821 | 2,862 | +57 | +2% | 76,800 |
2020/05/15 | 2,847 | 2,847 | 2,777 | 2,805 | -54 | -1.9% | 116,800 |
2020/05/14 | 2,950 | 2,950 | 2,842 | 2,859 | -105 | -3.5% | 110,600 |
2020/05/13 | 2,986 | 3,000 | 2,929 | 2,964 | -76 | -2.5% | 81,700 |
2020/05/12 | 2,990 | 3,085 | 2,970 | 3,040 | +71 | +2.4% | 49,100 |
2020/05/11 | 3,005 | 3,005 | 2,941 | 2,969 | +21 | +0.7% | 42,900 |
2020/05/08 | 3,025 | 3,045 | 2,926 | 2,948 | -38 | -1.3% | 57,400 |
2020/05/07 | 2,986 | 3,035 | 2,943 | 2,986 | +26 | +0.9% | 44,400 |
2020/05/01 | 2,900 | 2,972 | 2,888 | 2,960 | -16 | -0.5% | 62,000 |
2020/04/30 | 3,000 | 3,015 | 2,943 | 2,976 | +4 | +0.1% | 48,400 |
2020/04/28 | 2,980 | 2,980 | 2,900 | 2,972 | +8 | +0.3% | 24,700 |
2020/04/27 | 2,974 | 2,975 | 2,933 | 2,964 | -10 | -0.3% | 28,100 |
2020/04/24 | 2,999 | 2,999 | 2,949 | 2,974 | -8 | -0.3% | 25,100 |
2020/04/23 | 3,045 | 3,045 | 2,947 | 2,982 | +21 | +0.7% | 44,200 |
2020/04/22 | 2,940 | 2,992 | 2,914 | 2,961 | +21 | +0.7% | 43,400 |
2020/04/21 | 2,925 | 2,985 | 2,919 | 2,940 | -35 | -1.2% | 31,200 |
2020/04/20 | 2,950 | 2,989 | 2,947 | 2,975 | +9 | +0.3% | 33,600 |
2020/04/17 | 3,040 | 3,040 | 2,962 | 2,966 | -33 | -1.1% | 39,500 |
2020/04/16 | 2,940 | 3,040 | 2,927 | 2,999 | +62 | +2.1% | 48,300 |
2020/04/15 | 2,954 | 2,968 | 2,883 | 2,937 | -40 | -1.3% | 76,200 |
2020/04/14 | 2,905 | 3,070 | 2,905 | 2,977 | +122 | +4.3% | 111,500 |
2020/04/13 | 2,803 | 2,891 | 2,782 | 2,855 | +102 | +3.7% | 62,300 |
2020/04/10 | 2,700 | 2,772 | 2,684 | 2,753 | +119 | +4.5% | 54,100 |
2020/04/09 | 2,570 | 2,657 | 2,528 | 2,634 | +90 | +3.5% | 70,800 |
2020/04/08 | 2,563 | 2,601 | 2,468 | 2,544 | -19 | -0.7% | 60,200 |
2020/04/07 | 2,632 | 2,635 | 2,506 | 2,563 | -19 | -0.7% | 41,600 |
2020/04/06 | 2,490 | 2,585 | 2,465 | 2,582 | +57 | +2.3% | 33,900 |
2020/04/03 | 2,543 | 2,618 | 2,506 | 2,525 | -10 | -0.4% | 24,400 |
2020/04/02 | 2,573 | 2,600 | 2,506 | 2,535 | -53 | -2% | 42,700 |
2020/04/01 | 2,695 | 2,695 | 2,563 | 2,588 | -111 | -4.1% | 44,300 |
2020/03/31 | 2,685 | 2,751 | 2,651 | 2,699 | -11 | -0.4% | 80,300 |
2020/03/30 | 2,766 | 2,766 | 2,620 | 2,710 | +94 | +3.6% | 90,900 |
2020/03/27 | 2,480 | 2,616 | 2,430 | 2,616 | +135 | +5.4% | 91,300 |
1251~
1300
件表示中 / 3744件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 632,000円 | +7.1% | -35.0% | 0.00% | 52.26倍 | 1.46倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
ペプチド | 162,500円 | +5.0% | +1.5% | 0.00% | 13.90倍 | 3.69倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 423,000円 | +3.6% | +6.1% | 2.84% | 14.25倍 | 0.84倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
科研薬 | 385,500円 | -6.4% | -71.8% | 4.93% | 43.06倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 321,000円 | +7.9% | -3.3% | 2.49% | 8.93倍 | 0.92倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム